Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England

被引:145
|
作者
van Hoek, Albert Jan [1 ]
Sheppard, Carmen L. [2 ]
Andrews, Nick J. [1 ]
Waight, Pauline A. [1 ]
Slack, Mary P. E. [2 ]
Harrison, Timothy G. [2 ]
Ladhani, Shamez N. [1 ]
Miller, Elizabeth [1 ]
机构
[1] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London NW9 5EQ, England
[2] Publ Hlth England, Resp & Vaccine Preventable Bacteria Reference Uni, London NW9 5EQ, England
关键词
Nasopharynx; Carriage; Colonisation; Streptococcus pneumoniae; Pneumococcus; Conjugate vaccine; Vaccine impact; Post-PCV13; Herd immunity; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; SEROTYPE REPLACEMENT; 13-VALENT; IMMUNOGENICITY; DISEASE;
D O I
10.1016/j.vaccine.2014.03.017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background/Aims: In April 2010 the 7-valent pneumococcal conjugate vaccine (PCV7) was replaced by the 13-valent PCV. We investigated pneumococcal carriage in children eligible for PCV7 or PCV13 and their household contacts. Methods: Eligible families in Hertfordshire and Gloucester were identified and a nasopharyngeal swab obtained from consenting household members between July 2012 and March 2013. Samples were cultured for Streptococcus pneumoniae and serotyped by standard methods. For each serotype the ratio of its prevalence in invasive pneumococcal disease (IPD) to its carriage prevalence (case:carrier ratio, CCR) was calculated. Results were compared with previous carriage studies in 2001/2002 and 2008/2009, before and after PCV7 introduction. Results: 217 households were included. Among <5-year olds 47.7% (95% confidence interval 41.8-53.5) were carrying a pneumococcus compared with 51.0% (95% CI: 44.0-58.0) in 2008/2009 and 48.4% (95% CI: 44.1-52.7) in 2001/2002. The odds of carrying a PCV7 serotype was significantly reduced in 2008/2009 (0.07,95% CI: 0.03-0.16) and 2012/2013 (0.01 95% CI: 0.00-0.07) relative to 2001/2002, while the odds of carrying any of the extra six PCV13 serotypes increased after PCV7 introduction (1.38, 95%CI: 0.73-2.59) but declined significantly after PCV13 introduction (0.05, 95%CI: 0.01-0.37). The CCRs for the frequently carried serotypes were relatively low, with the highest CCR observed for serotypes 7F, 19A, 3, 8, and 33F. Across the three carriage studies, CCR estimates were stable for nearly all serotypes. Conclusion: Carriage of additional PCV13 serotypes has rapidly reduced post-PCV13 introduction in both vaccinated and unvaccinated individuals with a continued decline in transmission of PCV7 serotypes. Carriage rates in children remain unchanged, but the low CCRs of replacing serotypes would be expected to further reduce overall IPD across all age groups. (C) 2014 Published by Elsevier Ltd.
引用
收藏
页码:4349 / 4355
页数:7
相关论文
共 50 条
  • [31] PNEUMOCOCCAL MENINGITIS IN FRENCH CHILDREN BEFORE AND AFTER THE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINE
    Levy, Corinne
    Varon, Emmanuelle
    Bingen, Edouard
    Lecuyer, Aurelie
    Boucherat, Michel
    Cohen, Robert
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (02) : 168 - 170
  • [32] Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program
    Richter, Lukas
    Schmid, Daniela
    Kanitz, Elisabeth Eva
    Zwazl, Ines
    Poellabauer, Eva
    Jasinska, Joanna
    Burgmann, Heinz
    Kundi, Michael
    Wiedermann, Ursula
    PLOS ONE, 2019, 14 (01):
  • [33] Changing epidemiology of invasive pneumococcal disease in Australian children after introduction of a 7-valent pneumococcal conjugate vaccine
    Williams, Scott R.
    Mernagh, Paul J.
    Lee, Michael H. T.
    Tan, Jonathan T.
    MEDICAL JOURNAL OF AUSTRALIA, 2011, 194 (03) : 116 - 120
  • [34] Impact of 10-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children up to two years of age in Brazil
    Grando, Indianara Maria
    de Moraes, Camile
    Flannery, Brendan
    Ramalho, Walter Massa
    Horta, Marco Aurelio P.
    Moura Pinho, Diana Lucia
    Nascimento, Gilmara Lima
    CADERNOS DE SAUDE PUBLICA, 2015, 31 (02): : 276 - 284
  • [35] Pneumococcal Carriage Among Indigenous Kichwa Children From the Ecuadorian Andes After the 10-Valent Pneumococcal Vaccine Introduction
    Regalado, Daniela L.
    Rivera-Olivero, Ismar A.
    Garcia-Bereguiain, Miguel Angel
    Tana, Leandro
    Hernandez, Isabel
    Zurita, Jeannete
    Vidal, Jorge E.
    Teran, Enrique
    de Waard, Jacobus H.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (11) : E427 - E433
  • [36] Impact of thirteen-valent pneumococcal conjugate vaccine on nasopharyngeal carriage in healthy children under 24 months in Okinawa, Japan
    Chang, Bin
    Akeda, Hideki
    Nakamura, Yoshihisa
    Hamabata, Hirotsune
    Ameku, Kenji
    Toma, Takaya
    Miyagi, Masaya
    Ohnishi, Makoto
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (05) : 465 - 470
  • [37] Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage Among American Indians
    Grant, Lindsay R.
    Hammitt, Laura L.
    O'Brien, Sarah E.
    Jacobs, Michael R.
    Donaldson, Connie
    Weatherholtz, Robert C.
    Reid, Raymond
    Santosham, Mathuram
    O'Brien, Katherine L.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (08) : 907 - 914
  • [38] Pneumococcal Infection among Children before Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Cambodia
    Turner, Paul
    Turner, Claudia
    Suy, Kuong
    Soeng, Sona
    Ly, Sokeng
    Miliya, Thyl
    Goldblatt, David
    Day, Nicholas P. J.
    EMERGING INFECTIOUS DISEASES, 2015, 21 (11) : 2080 - 2083
  • [39] Nasopharyngeal Carriage in Children After the Introduction of Generalized Infant Pneumococcal Conjugate Vaccine Immunization in Germany
    Rose, Markus A.
    Laurenz, Maren
    Sprenger, Ralf
    Imoehl, Matthias
    van der Linden, Mark
    FRONTIERS IN MEDICINE, 2021, 8
  • [40] Pneumococcal Nasopharyngeal Carriage following Reduced Doses of a 7-Valent Pneumococcal Conjugate Vaccine and a 23-Valent Pneumococcal Polysaccharide Vaccine Booster
    Russell, F. M.
    Carapetis, J. R.
    Satzke, C.
    Tikoduadua, L.
    Waqatakirewa, L.
    Chandra, R.
    Seduadua, A.
    Oftadeh, S.
    Cheung, Y. B.
    Gilbert, G. L.
    Mulholland, E. K.
    CLINICAL AND VACCINE IMMUNOLOGY, 2010, 17 (12) : 1970 - 1976